153 related articles for article (PubMed ID: 9519891)
1. Analysis of a biallelic polymorphism in the tumor necrosis factor alpha promoter and HIV type 1 disease progression.
Knuchel MC; Spira TJ; Neumann AU; Xiao L; Rudolph DL; Phair J; Wolinsky SM; Koup RA; Cohen OJ; Folks TM; Lal RB
AIDS Res Hum Retroviruses; 1998 Mar; 14(4):305-9. PubMed ID: 9519891
[TBL] [Abstract][Full Text] [Related]
2. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
[TBL] [Abstract][Full Text] [Related]
3. Association of CCR5-59029 A/G and CCL3L1 copy number polymorphism with HIV type 1 transmission/progression among HIV type 1-seropositive and repeatedly sexually exposed HIV type 1-seronegative North Indians.
Rathore A; Chatterjee A; Sivarama P; Yamamoto N; Singhal PK; Dhole TN
AIDS Res Hum Retroviruses; 2009 Nov; 25(11):1149-56. PubMed ID: 19886839
[TBL] [Abstract][Full Text] [Related]
4. Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.
Hladik F; Liu H; Speelmon E; Livingston-Rosanoff D; Wilson S; Sakchalathorn P; Hwangbo Y; Greene B; Zhu T; McElrath MJ
J Virol; 2005 Sep; 79(18):11677-84. PubMed ID: 16140745
[TBL] [Abstract][Full Text] [Related]
5. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
[TBL] [Abstract][Full Text] [Related]
6. Host genetic background at CCR5 chemokine receptor and vitamin D receptor loci and human immunodeficiency virus (HIV) type 1 disease progression among HIV-seropositive injection drug users.
Barber Y; Rubio C; Fernández E; Rubio M; Fibla J
J Infect Dis; 2001 Nov; 184(10):1279-88. PubMed ID: 11679916
[TBL] [Abstract][Full Text] [Related]
7. Stromal cell-derived factor (SDF) 1-3'A polymorphism may play a role in resistance to HIV-1 infection in seronegative high-risk Thais.
Tiensiwakul P
Intervirology; 2004; 47(2):87-92. PubMed ID: 15192272
[TBL] [Abstract][Full Text] [Related]
8. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk.
Zimmerman PA; Buckler-White A; Alkhatib G; Spalding T; Kubofcik J; Combadiere C; Weissman D; Cohen O; Rubbert A; Lam G; Vaccarezza M; Kennedy PE; Kumaraswami V; Giorgi JV; Detels R; Hunter J; Chopek M; Berger EA; Fauci AS; Nutman TB; Murphy PM
Mol Med; 1997 Jan; 3(1):23-36. PubMed ID: 9132277
[TBL] [Abstract][Full Text] [Related]
9. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
Paxton WA; Kang S; Koup RA
AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S89-92. PubMed ID: 9581891
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms within the human tumor necrosis factor-alpha promoter region in human immunodeficiency virus type 1-seropositive persons.
Brinkman BM; Keet IP; Miedema F; Verweij CL; Klein MR
J Infect Dis; 1997 Jan; 175(1):188-90. PubMed ID: 8985218
[TBL] [Abstract][Full Text] [Related]
11. [Comparative analysis of distribution of mutant alleles of the gene coding for the CCR-5 chemokine receptor, among people in Russia, infected and not infected with HIV-1].
Kazennova EV; Aarons E; Selimova LM; Ladnaia NN; Kravchenko AV; Zhemchugov VE; Chaingon-Popov R; Weber J; Pokrovskiĭ VV; Bobkov AF
Vopr Virusol; 1998; 43(1):30-2. PubMed ID: 9559533
[TBL] [Abstract][Full Text] [Related]
12. Lack of effect of chemokine receptor CCR2b gene polymorphism (64I) on HIV-1 plasma RNA viral load and immune activation among HIV-1 seropositive female workers in Abidjan, Côte d'Ivoire.
Adjé CA; Bilé CE; Kestens L; Koblavi-Deme S; Ghys PD; Maurice C; Kalou-Badirou M; Kabran N; Ekpini RE; Roels TH; Wiktor SZ; Nkengasong JN
J Med Virol; 2001 Aug; 64(4):398-401. PubMed ID: 11468722
[TBL] [Abstract][Full Text] [Related]
13. Stromal cell-derived factor 1 (SDF1) genetic polymorphism in a sample of healthy individuals, seronegative individuals exposed to human immunodeficiency virus type 1 (HIV-1) and patients infected with HIV-1 from the Brazilian population.
Reiche EM; Watanabe MA; Bonametti AM; Morimoto HK; Morimoto AA; Wiechmann SL; Matsuo T; Miranda HC; Reiche FV; Oliveira KB
Int J Immunogenet; 2006 Apr; 33(2):127-33. PubMed ID: 16611258
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin.
Garred P; Madsen HO; Balslev U; Hofmann B; Pedersen C; Gerstoft J; Svejgaard A
Lancet; 1997 Jan; 349(9047):236-40. PubMed ID: 9014910
[TBL] [Abstract][Full Text] [Related]
15. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study.
McDermott DH; Beecroft MJ; Kleeberger CA; Al-Sharif FM; Ollier WE; Zimmerman PA; Boatin BA; Leitman SF; Detels R; Hajeer AH; Murphy PM
AIDS; 2000 Dec; 14(17):2671-8. PubMed ID: 11125885
[TBL] [Abstract][Full Text] [Related]
16. Effect of TNF-alpha genetic variants and CCR5 Delta 32 on the vulnerability to HIV-1 infection and disease progression in Caucasian Spaniards.
Veloso S; Olona M; García F; Domingo P; Alonso-Villaverde C; Broch M; Peraire J; Viladés C; Plana M; Pedrol E; López-Dupla M; Aguilar C; Gutiérrez M; Leon A; Tasias M; Gatell JM; Richart C; Vidal F
BMC Med Genet; 2010 Apr; 11():63. PubMed ID: 20420684
[TBL] [Abstract][Full Text] [Related]
17. Chemokine receptor CCR2b 64I polymorphism and its relation to CD4 T-cell counts and disease progression in a Danish cohort of HIV-infected individuals. Copenhagen AIDS cohort.
Eugen-Olsen J; Iversen AK; Benfield TL; Koppelhus U; Garred P
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):110-6. PubMed ID: 9637575
[TBL] [Abstract][Full Text] [Related]
18. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
[TBL] [Abstract][Full Text] [Related]
19. CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status.
Hoffman TL; MacGregor RR; Burger H; Mick R; Doms RW; Collman RG
J Infect Dis; 1997 Oct; 176(4):1093-6. PubMed ID: 9333175
[TBL] [Abstract][Full Text] [Related]
20. Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors.
Cohen OJ; Vaccarezza M; Lam GK; Baird BF; Wildt K; Murphy PM; Zimmerman PA; Nutman TB; Fox CH; Hoover S; Adelsberger J; Baseler M; Arthos J; Davey RT; Dewar RL; Metcalf J; Schwartzentruber DJ; Orenstein JM; Buchbinder S; Saah AJ; Detels R; Phair J; Rinaldo C; Margolick JB; Pantaleo G; Fauci AS
J Clin Invest; 1997 Sep; 100(6):1581-9. PubMed ID: 9294127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
